Study of Normal Conditions of Use, Dosing, and Safety of Intravenous (IV) Administration of Vernakalant (MK-6621-049)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01370629
Recruitment Status : Completed
First Posted : June 10, 2011
Last Update Posted : May 10, 2018
Information provided by (Responsible Party):
Cardiome Pharma

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 5, 2018
  Actual Study Completion Date : May 8, 2018